GlassScriptPhysician profile
Jenna B Pitman
NPI 1427349711
$598.67
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $216 · 2022: $251 · 2023: $87.59 · 2024: $43.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $141.78 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $58.66 | 2021-2022 | |
| Glaxosmithkline, LLC. | $51.63 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $50.17 | 2021-2022 | |
| Novo Nordisk INC | $46.17 | 2021-2024 | Ozempic, Rybelsus |
| Alkermes, INC. | $45.02 | 2022-2023 | Lybalvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.60 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $35.92 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $27.21 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $26.84 | 2024 | Fanapt |
| Sunovion Pharmaceuticals INC. | $19.96 | 2022 | |
| Medtronic, INC. | $18.37 | 2021 | |
| Allergan, INC. | $15.94 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $12.22 | 2021 | |
| Lilly USA, LLC | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Pitman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.